Navigation Links
The Olive Branch Fund Announces Funding Award to Harvard Researcher
Date:6/29/2011

NASHVILLE, Tenn., June 29, 2011 /PRNewswire-USNewswire/ -- The Olive Branch Fund: A Thisbe and Noah Scott Legacy, an organization dedicated to combating pediatric motor neuron diseases, today announced its first funding award to Kevin Eggan, Ph.D., Associate Professor of Stem Cell and Regenerative Biology at Harvard University.  The award will support Dr. Eggan's ongoing research investigating the neuromuscular system and the diseases that affect it.  Dr. Eggan is a leading researcher in motor neuron disease. He received the MacArthur Fellowship in 2006 and received the Presidential Early Career Award for Science and Engineering from President George Bush in 2008.

"This initial grant to Dr. Eggan is an incredibly exciting milestone for us as we begin to invest the funds we have raised to support the mission of The Olive Branch Fund and to advance groundbreaking research in the fight against motor neuron disease.  We are pleased this award will support Dr. Eggan's important research while also providing clues into the mechanisms of Brown-Vialetto-Van Laere syndrome," said Laurian Scott, Co-Founder of The Olive Branch Fund.  Brown-Vialetto-Van Laere syndrome is a rare, progressive, neurodegenerative motor neuron disorder that specifically includes palsies (paralysis) of the cranial nerves, and is sometimes referred to as "bulbar palsy."  Throughout the past century, few cases of Brown-Vialetto-Van Laere have been reported in the literature, but those numbers are growing.

The Olive Branch Fund: A Thisbe and Noah Scott Legacy was formed in 2008 to promote research, awareness, and support for families of all pediatric motor neuron diseases in memory of Laurian and John Scott's two children, Noah, who passed away at 19 months, and Thisbe, who passed away just before her third birthday.  Six cities nationwide, including Nashville, Memphis, Richmond, and Phoenix, have held fundraisers for The Olive Branch Fund, raising over $500,000.  These fundraisers are titled "A Mighty Voice" and aid The Olive Branch Fund in carrying out its mission worldwide.

The Olive Branch Fund: A Thisbe and Noah Scott Legacy is a component fund of the Community Foundation of Middle Tennessee.  For more information, please visit www.theolivebranchfund.org.


'/>"/>
SOURCE The Olive Branch Fund
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. New antioxidant compounds have been identified in foods such as olive oil, honey and nuts
2. New antioxidant compounds have been identified in foods such as olive oil, honey and nuts
3. Powered by olive stones? Turning waste stones into fuel
4. Rcadia COR Analyzer System Safely Rules Out Coronary Artery Disease in Main Coronary Arteries and Branch Vessels
5. Edwin Rivera-Martinez, Former Chief of the FDA’s International Compliance Branch, Joins PAREXEL Consulting Strategic Compliance Team
6. Pharma ChemOutsourcing Unveils 100 Pharma & Biotech Speaker Faculty for 2009 Conference September 14-16 in Long Branch, NJ
7. Stunning Attendance for ChemOutsourcing Show on September 8-9 in Long Branch, NJ
8. Verenium Announces Signing of Lease for New Office and Lab Space
9. Celladon Corporation Announces Publication of Advanced Heart Failure Clinical Trial Results With MYDICAR® Enzyme Replacement Therapy in the Journal Circulation
10. Scotland Announces Goal to Double Life Sciences Contribution to Scottish Economy by 2020 at BIO
11. PharmacoFore, Inc. Announces Appointment of Chief Medical Officer and Vice President of Intellectual Property
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016   EpiBiome , ... secured $1 million in debt financing from Silicon Valley ... up automation and to advance its drug development efforts, ... new facility. "SVB has been an incredible ... the services a traditional bank would provide," said Dr. ...
(Date:6/23/2016)... ... June 23, 2016 , ... STACS DNA Inc., the sample tracking software company, ... Crime Laboratory, has joined STACS DNA as a Field Application Specialist. , “I ... President and COO of STACS DNA. “In further expanding our capacity as a scientific ...
(Date:6/23/2016)... 2016 Apellis Pharmaceuticals, Inc. today announced ... of its complement C3 inhibitor, APL-2. The trials ... dose studies designed to assess the safety, tolerability, ... in healthy adult volunteers. Forty subjects ... single dose (ranging from 45 to 1,440mg) or ...
(Date:6/23/2016)... 23, 2016 Andrew ... http://doi.org/10.17925/OHR.2016.12.01.22 Published recently in ... journal from touchONCOLOGY, Andrew D Zelenetz , ... cancer care is placing an increasing burden on ... biologic therapies. With the patents on many biologics ...
Breaking Biology Technology:
(Date:6/3/2016)... , June 3, 2016 ... von Nepal hat ... Lieferung hochsicherer geprägter Kennzeichen, einschließlich Personalisierung, Registrierung ... in der Produktion und Implementierung von Identitätsmanagementlösungen. ... Ausschreibung im Januar teilgenommen, aber Decatur wurde ...
(Date:6/1/2016)... NEW YORK , June 1, 2016 ... Biometric Technology in Election Administration and Criminal Identification to ... According to a recently released TechSci Research report, " ... Sector, By Region, Competition Forecast and Opportunities, 2011 - ... $ 24.8 billion by 2021, on account of growing ...
(Date:5/12/2016)... May 12, 2016 WearablesResearch.com , a ... the overview results from the Q1 wave of its ... wave was consumers, receptivity to a program where they ... a health insurance company. "We were surprised ... says Michael LaColla , CEO of Troubadour Research, ...
Breaking Biology News(10 mins):